- Home
- CRBG vs HOLX Comparison
CRBG vs HOLX Comparison
Compare CRBG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBG | HOLX |
|---|---|---|
| Founded | 1957 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 16.9B |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CRBG | HOLX |
|---|---|---|
| Price | $27.18 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | $35.15 | ★ $77.89 |
| AVG Volume (30 Days) | 4.7M | ★ 25.5M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $18,481,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $16.24 | $4.74 |
| Revenue Next Year | $5.65 | $5.03 |
| P/E Ratio | ★ N/A | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $22.19 | $51.90 |
| 52 Week High | $36.57 | $76.07 |
Technical Indicators
Market Signals| Indicator | CRBG | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 69.09 |
| Support Level | $22.26 | $75.10 |
| Resistance Level | $27.82 | N/A |
| Average True Range (ATR) | 0.77 | 0.19 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 83.14 | 95.19 |
Price Performance
Historical ComparisonAbout CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.